Norges Bank Purchases New Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
Norges Bank bought a new position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 849,389 shares of the company’s stock, valued at approximately $4,706,000. Several other hedge funds and other institutional investors also recently added to or reduced […]
Norges Bank bought a new position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 849,389 shares of the company’s stock, valued at approximately $4,706,000. Several other hedge funds and other institutional investors also recently added to or reduced […]